Apigenin not only reduced the expression of different tumor-causing genes such as TNF-α, IL-6 and CD40, but also increased the activity of the tumor-suppressing STAT1 gene via IFN-γ gene inhibition [16]. The gene discussed is CD40; the disease is neoplasm.